Antitumor effects of interleukin-2 gene-modified fibroblasts in an orthotopic colon cancer model
- PMID: 10551331
- PMCID: PMC5926163
- DOI: 10.1111/j.1349-7006.1999.tb00848.x
Antitumor effects of interleukin-2 gene-modified fibroblasts in an orthotopic colon cancer model
Abstract
We transduced the interleukin-2 (IL-2) gene into murine fibroblasts BALBCL7 or murine colon cancer CT26 using a retroviral vector. BALBCL7 transduced with IL-2 gene secreted 748 pg/ml of IL-2, whereas IL-2 gene-modified CT26 secreted 1,167 pg/ml of IL-2 (48 h incubation, 1x10(6)/ml). Then, we inoculated gene-modified BALBCL7 and/or CT26 cells into BALB/c female mice, and observed the tumor growth. The tumor growth was inhibited in mice inoculated with parental CT26 plus IL-2 gene-modified BALBCL7, compared with that in mice given parental CT26 alone (P<0.01). Moreover, we investigated the cytotoxic activity of spleen cells derived from mice treated with gene-modified cells, and performed phenotypic analysis of the effector cells. The killer cells derived from mice inoculated with IL-2 gene-modified BALBCL7 plus parental CT26 showed higher cytotoxic activity than those from mice inoculated with CT26 alone. The cytotoxic activity was almost completely blocked by anti-CD8 antibody (Ab), and partially blocked by anti-asialo GM1 Ab. Next, we inoculated CT26 tumor tissue into murine cecum orthotopically, and treated the animals with gene-modified BALBCL7 plus parental CT26. The tumor size in the cecum was significantly decreased, compared with parental CT26 alone (P<0.01).
References
-
- Fearon , E. R. , Pardoll , D. M. , Itaya , T. , Golumbek , P. , Levitsky , H. I. , Simons , J. W. , Karasuyama , H. , Vogelstein , B. and Frost , P.Interleukin‐2 production by tumor cells bypasses T helper function in the generation of an antitumor response . Cell , 60 , 397 – 403 ( 1990. ). - PubMed
-
- Yannelli , J. R. , Hyatt , C. , Johnson , S. , Hwu , P. and Rosenberg , S. A.Characterization of human tumor cell lines transduced with the cDNA encoding either TNF‐α or IL‐2 . J. Immunol. Methods , 161 , 77 – 90 ( 1993. ). - PubMed
-
- Veelken , H. , Jesuiter , H. , Mackensen , A. , Kulmburg , P. , Schultze , J. , Rosenthal , F. , Mertelsmann , R. and Linde‐mann , A.Primary fibroblasts from human adults as target cells for ex vivo transfection and gene therapy . Human Gene Ther. , 5 , 1203 – 1210 ( 1994. ). - PubMed
MeSH terms
Substances
LinkOut - more resources
Research Materials